In this study we aimed to investigate the frequency, titer, efficacy, and kinetics of immunoglobulins response (IgG, IgM, and IgA) of COVID-19 patients, COVID-19 vaccine recipients and random individuals. This evidence concerns the gene CD40LG and COVID-19.